Main Article Content

Abstract

Neonatal hyperbilirubinemia results from a readiness for the bilirubin production in neonates and limited their ability to excrete it. The diagnosis of hyperbilirubinemia based on yellow discoloration of the skin and whiteness of eyes, idle in the child's movement and the lack of lactation. The baby seems sick or is difficult to awaken.  Bilirubin is a tetrapyrrole pigment derived from breakdown product of normal heme catabolism in senescent red blood cells. Unconjugated bilirubin normal elevation is named newborn physiologic hyperbilirubinemia, whereas the level of bilirubin of infant normally to be a bit higher after birth, In the same context the placenta in the womb of the mother. Pathologic hyperbilirubinemia is defined as odd of bilirubin from the normal level so intervention required. Many reasons for this type of jaundice

Keywords

Hyperbilirubinemia Bilirubin Neonate Junduice

Article Details

How to Cite
Aljazaeri, S. A. (2021). Neonatal Hyperbilirubinemia, Types, Causes and Treatments: A Review Study. Medical Science Journal for Advance Research, 2(2), 76–79. https://doi.org/10.46966/msjar.v2i2.23

References

  1. American Academy of Pediatrics (AAP), (1994). Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn. Pediatrics, 94:558-566.
  2. Bertini, G.; Dani, C.; Trochin, M. and Rubaltelli, F., (2001). Is breastfeeding really favoring early neonatal jaundice? Pediatrics, 107(3): 41.
  3. Bryon, J.; Lauer, M.D.; Nancy, D. and Spector, M.D., (2011). Hyper- bilirubinemia in the Newborn. Pediatrics in Review, Vol.32(8).
  4. Buescher, JJ. ; Bland, H.,(2011) . Care of the newborn. In: Rakel RE, ed. Textbook of Family Medicine. 8th ed. Philadelphia, PA: Saunders Elsevier; chap 22.
  5. Cabra, M.A.; Whitfield, J.M., (2005). The challenge of pre venting neonatal bilirubin encephalopathy: a new nursing protocol in the well newborn nursery. Proceedings (Bayl Univ Med Cent), 18: 217–9.
  6. Click, R.; Dahl-Smith J.; Fowler, L.; DuBose, J.; Deneau-Saxton, M. and Herbert, J., (2013). An osteopathic approach to reduction of read- missions for neonatal jaundice. Osteopath Fam Physician,5:17-23.
  7. Col, PV. Rama Mohan; Wg Cdr M Kumar; Maj R Pacharu,(2011). Mirizzi syndrome. MJAFI .67:280–281.
  8. Dennery, PA.; Seidman, DS. and Stevenson, DK., (2001). Neonatal hyperbilirubinemia, N Engl J Med.,344:581–590.
  9. Elizabete, P.; Maria, A M. and Fernando P. F., (2011). Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks. J Pediatr.,87(4):301-306.
  10. Gartner, L. M.; Herschel, M., (2001). Jaundice And Breastfeeding. Pediatric Clinics of North America, Vol.48(2): 389–400.
  11. Huang, L. ; Bao, Y. ; Xu, Z. ; Lei, X. ; Chen, Y. ;Zhang, Y. ; Zhang, J. , (2013). Neonatal bilirubin levels and childhood asthma in the US Collaborative Perinatal Project, 1959–1965. Am J Epidemiol. 178(12):1691–1697.
  12. Kaplan, M.; Hammerman C., (2002). Glucose-6- phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol.,7(2):121–128.
  13. Kuzniewicz, M.W.; Escobar, G.J.; Wi, S.; Liljestrand, P.; McCulloch C. ; Newman, T.B. , (2008). Risk factors for severe hyper- bilirubinemia among infants with borderline bilirubin levels: a nested case-control study. J Pediatr. 153(2):234–240.
  14. Logeshwaran, R.; Siva, K. P.; Kuldeep, S.; Pravin K. S., (2013). A Novel Design of Low-Cost LED Photo Therapy Equipment. Bachelor of Engineering, Associate Professor - Department of Biomedical Engineering, Sri Sivasubramaniya Nadar College of Engineering, Tamil Nadu, India Master of Science, Arizona State University, U.S.A. International Journal of Engineering & Technology Research, Vol (1), Issue 2: pp. 46-51.
  15. Lynn, C.; Garfunkel, J.; Cynthia C.., (2002). Mosby's pediatric clinical advisor: instant diagnosis and treatment. Elsevier Health Sciences. pp. 200. ISBN 978-0-323-01049-8.
  16. Maisels, MJ., (1999). Jaundice. In Neonatology, Pathophysiology & Management of the Newborn, eds. Avery GB, Fletcher MA, & MacDonald MG, pp. 765-820. Lippincott Williams & Wilkins, Philadelphia.
  17. Maruo, Y.; Morioka, Y.; Fujito, H.; Nakahara, S.; Yanagi, T.; Matsui, K.; Mori, A.; Sato, H.; Tukey, R.H.; Takeuchi, Y., (2014). Bilirubin Uridine Diphosphate-Glucuronosyltransferase Variation Is a Genetic Basis of Breast Milk Jaundice..J Pediatr .165:36-41.
  18. Mary Ann Liebert, (2010). ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant Equal to or Greater Than 35 Weeks’ Gestation. The Academy of Breastfeeding Medicine Protocol Committee. Inc., vol.5(2).
  19. Mehta, S.; Kumar, P.; Narang, A., (2005). A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr .147:781-5.
  20. National Blood Authority Australia (NBAA), (2012). Standing Council on Health. Criteria for the clinical use of intravenous immunoglobulin in Australia. Second edition.
  21. National Institute for Health and Clinical Excellence (NIHCE), (2010). Neonatal jaundice. CG98. London: National Insititute for Health and Clinical Excellence.
  22. Porter, ML. ; Dennis, BL.,(2002) . "Hyperbilirubinemia in the term new- born". Am Fam Physician, 65(4):599–606.
  23. Practice parameter (PP), (1994). "management of hyperbilirubinemia in the healthy term newborn". Pediatrics .944 pt 1:558–62.
  24. Rennie, J.; Burman-Roy, S. and Murphy, M.S., (2010). Neonatal jaundice: summary of NICE guidance. BMJ., 340:c2409.
  25. Robert, M. ; Kliegman, Richard E. ;Behrman, Bal B. ;Jenson, S. Abramson, et al. ,(2011). "Neonatal Jaundice". Nelson text book of Pediatrics 19th Edition.Chapter96.3.page 603.
  26. Watchko, J.F.; Maisels, MJ., (2003). Jaundice in low birthweight Infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 88: F455–F458.
  27. Yang, W.C.; Zhao, L.L.; Li, Y.C.; Chen, C.H.; Chang, Y.J; Fu, Y.C.; Wu, H.P. et al. (2013). Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatrics, 13:154.